A Pan-Cancer Analysis of the Oncogenic Role of <i>BCL7B</i>: A Potential Biomarker for Prognosis and Immunotherapy.

导出 LinkOut

翻译打印收藏纠错

作者： Dinglong,Yang ^[1] ; Hetong,Li ^[1] ; Yujing,Chen ^[2] ; Chunjiang,Li ^[3] ; Weiping,Ren ^[3] ; Yongbo,Huang ^[3]

作者单位： Second Clinical Medical College, Shanxi Medical University, Taiyuan, China. ^[1] School of Public Health, Xi'an Jiaotong University, Xian, China. ^[2] Department of Orthopedics, The Second Hospital of Shanxi Medical University, Taiyuan, China. ^[3]

关键词 BCL7B TCGA bioinformatics immune infiltration pan-cancer prognosis

DOI 10.3389/fgene.2022.906174

PMID 35910232

发布时间 2022-08-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in genetics

2022年13卷

906174页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Pan-Cancer Analysis of the Oncogenic Role of <i>BCL7B</i>: A Potential Biomarker for Prognosis and Immunotherapy.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Pan-Cancer Analysis of the Oncogenic Role of <i>BCL7B</i>: A Potential Biomarker for Prognosis and Immunotherapy.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

检索历史清除